Renaissance BioScience Expands RNA Technology Patent Portfolio with Mexican Grant
TL;DR
Renaissance BioScience's new patent strengthens its IP portfolio, offering competitive production costs for RNA-based biopesticides that outperform chemical alternatives.
Renaissance BioScience's yeast-based platform enables low-cost RNA production and delivery, integrating with existing farming practices to create targeted RNAi biopesticides.
This technology reduces environmental harm by replacing broad-spectrum pesticides with precise biopesticides, making agriculture safer and more sustainable.
A Canadian company now holds patents in three countries for yeast that produces RNA molecules, opening possibilities beyond pest control.
Found this article helpful?
Share it with your network and spread the knowledge!
Renaissance BioScience Corp. has been granted a patent by the Mexican patent office for its innovative yeast-based platform technology that enables low-cost production and effective delivery of RNA. This represents the third patent issued for the company's RNA technology following earlier grants in China and Australia, with additional jurisdictions pending. The new patent expands Renaissance's intellectual property portfolio of issued and pending patents for yeast-based technology across multiple end-use markets.
The company's most advanced commercial application of this RNA production and delivery system is a suite of RNAi-based biopesticide products that provide precise, targeted pest control. These products offer a strong environmental safety profile compared with broad-spectrum chemical pesticides while maintaining competitive production costs at scale. The technology integrates smoothly into current farming practices and equipment, potentially offering farmers an effective alternative to traditional chemical pesticides.
Dr. John Husnik, Renaissance's Chief Scientific Officer and member of the Office of the CEO, stated that the Mexican patent confirms the novelty and importance of the company's yeast-based RNA technology for producing, protecting and delivering next-generation RNA bioactive molecules. He noted that in addition to biopesticides, this platform offers opportunities across a wide range of multi-billion-dollar commercial markets.
This development is significant because it represents continued international recognition of Renaissance's proprietary technology at a time when sustainable agricultural solutions are increasingly sought after globally. The expansion of patent protection into Mexico, a major agricultural market, could facilitate market entry and adoption of the company's biopesticide products in North America. More information about the company's technology and applications is available at https://www.renaissancebioscience.com.
The patent grant strengthens Renaissance's competitive position in the growing market for biological crop protection products. As regulatory pressures increase on traditional chemical pesticides and consumer demand grows for sustainably produced food, technologies like Renaissance's RNA-based biopesticides could see accelerated adoption. The company's ability to secure patents in multiple jurisdictions suggests the technology has broad applicability and commercial potential beyond its initial agricultural focus.
Curated from 24-7 Press Release
